Ruben Raychaudhuri (@rubenraychaud) 's Twitter Profile
Ruben Raychaudhuri

@rubenraychaud

Assistant professor @fredhutch @uwmedicine former @pennIMresidents . interested in GU medical oncology, clinical trials

ID: 1664694034399371264

calendar_today02-06-2023 18:03:06

7 Tweet

98 Takipçi

135 Takip Edilen

Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC (@avirupguha) 's Twitter Profile Photo

Our #prostatecancer group led by #MahaHussain Ruth O'Regan #ShingLee #SanfordJeames at AACR ASCO methods in clinical cancer research conference #MCCR23 #VailWorkshop. Such excellent trials developed in this one of a kind workshop.

Our #prostatecancer group led by #MahaHussain <a href="/oreganruth/">Ruth O'Regan</a> #ShingLee #SanfordJeames at <a href="/AACR/">AACR</a> <a href="/ASCO/">ASCO</a> methods in clinical cancer research conference #MCCR23 #VailWorkshop. Such excellent trials developed in this one of a kind workshop.
UroToday.com (@urotoday) 's Twitter Profile Photo

#PLATIPARP: A phase 2 study of induction docetaxel and carboplatin followed by maintenance rucaparib in treatment of pts with #mCRPC with homologous recombination DNA repair deficiency Ruben Raychaudhuri Fred Hutch Cancer Center. #ASCO24 written coverage by @rksayyid > bit.ly/4e30T59

#PLATIPARP: A phase 2 study of induction docetaxel and carboplatin followed by maintenance rucaparib in treatment of pts with #mCRPC with homologous recombination DNA repair deficiency <a href="/RubenRaychaud/">Ruben Raychaudhuri</a> <a href="/fredhutch/">Fred Hutch Cancer Center</a>. #ASCO24 written coverage by @rksayyid &gt; bit.ly/4e30T59
European Urology (@euplatinum) 's Twitter Profile Photo

Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial by Ruben Raychaudhuri et al. Full article: europeanurology.com/article/S0302-…

Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial by <a href="/RubenRaychaud/">Ruben Raychaudhuri</a> et al.

Full article: europeanurology.com/article/S0302-…
Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo

Please do read our letter to editor to Journal of Clinical Oncology with regards to the recent publication of the ARANOTE trial. Until when shall we put up with inferior control arms? Congratulations Abhenil Mittal for raising awareness re this important issue. ascopubs.org/doi/10.1200/JC…

Please do read our letter to editor to <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> with regards to the recent publication of the ARANOTE trial. Until when shall we put up with inferior control arms? 
Congratulations <a href="/abhenilmittal/">Abhenil Mittal</a> for raising awareness re this important issue. 

ascopubs.org/doi/10.1200/JC…
Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Ab#769 ASCO #GU25  👉Congrats Ruben Raychaudhuri Petros Grivas👉bit.ly/3EqFDsD👉Ph2 trial of neoadj pembro + aMVAC in pts w/ non-urothelial MIBC #bladdercancer👉pCR 53%, median EFS 38 mos & median OS NR👉Promising data👇 OncoAlert UroToday.com @BladdercancerUS

Ab#769 <a href="/ASCO/">ASCO</a> #GU25  👉Congrats <a href="/RubenRaychaud/">Ruben Raychaudhuri</a> <a href="/PGrivasMDPhD/">Petros Grivas</a>👉bit.ly/3EqFDsD👉Ph2 trial of neoadj pembro + aMVAC in pts w/ non-urothelial MIBC #bladdercancer👉pCR 53%, median EFS 38 mos &amp; median OS NR👉Promising data👇 <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a> @BladdercancerUS
Uromigos (@uromigos) 's Twitter Profile Photo

The UromigosLive 2025 meeting presents #UromigosShorts videos on GU Oncology topics. The videos with the most views win a prize at #UromigosLive November 7-8th in Nashville, TN. Below, Dr. Omar Mian discusses: Metastasis-directed Therapy in Prostate Cancer.